A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies

Completed · Phase 2

Conditions studied: Melanoma

In brief

The purpose of this study was to evaluate the continued use of ipilimumab in patients who had reinduction at the time of disease progression or to continue maintenance treatment. In addition, this study will continue to follow patients who have taken ipilimumab, but who are not eligible for maintenance or reinduction therapy.

Key facts

Study ID

NCT00162123

Run by

Bristol-Myers Squibb

People needed

248

Starts

2006-05-01

Expected to finish

2014-04-01

Last updated by the study team

2016-07-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Wilshire Oncology Medical Group Inc — Laverne, California, United States
• The Angeles Clinic & Research Inst. — Los Angeles, California, United States
• Usc/Norris Comprehensive Cancer Center — Los Angeles, California, United States
• San Francisco Oncology Associates — San Francisco, California, United States
• Local Institution — To Come, Connecticut, United States
• Baptist Cancer Institute — Jacksonville, Florida, United States
• University Of Chicago — Chicago, Illinois, United States
• Indiana Oncology Hematology Consultants — Indianapolis, Indiana, United States
• St Joseph Oncology Inc — Saint Joseph, Missouri, United States
• Washington University School Of Medicine — St Louis, Missouri, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• Carolinas Medical Center — Charlotte, North Carolina, United States
• The Christ Hospital Cancer Center Research — Cincinnati, Ohio, United States
• Providence Portland Medical Center — Portland, Oregon, United States
• Cancer Centers Of The Carolinas — Greenville, South Carolina, United States
• Center For Oncology Research & Treatment, P.A. — Dallas, Texas, United States
• Joe Arrington Cancer Research And Treatment Center — Lubbock, Texas, United States
• University Of Washington Medical Center — Seattle, Washington, United States
• Local Institution — Buenos Aires, Buenos Aires, Argentina
• Local Institution — Vienna, Austria
• Local Institution — Wels, Austria
• Local Institution — Brussels, Belgium
• Local Institution — Brussels, Belgium
• Local Institution — Brussels, Belgium
• University Of Arizona Cancer Center — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.